Moving Beyond Truvada for PrEP: The Next Generation of Biomedical HIV Prevention and What It Means for Los Angeles

On Thursday, July 14, 2016 – Drs. Steve Shoptaw, Raphael Landovitz, and Jesse Clark presented at the Los Angeles County Commission on HIV meeting, as part of the CHIPTS HIV Research and Community Colloquia Series.  Their presentation, “Moving Beyond Truvada for PrEP: The Next Generation of Biomedical HIV Prevention and What It Means for Los […]

Please watch a fantastic TED talk from one of our best, Dr. Raphy Landovitz. Please share with others.

Published on Jul 8, 2016 “Preventive Medicine” has arrived for those at risk for HIV. New medical strategies are available to help prevent HIV from being transmitted. As futuristic as this concept seems, it is part of a preventive revolution for medical care – where an “ounce of prevention” may be worth more than a […]

Igniting Conversation in Latino Communities on HIV Treatment and Medication Adherence Through the Use of Telenovelas: Sin Verguenza Season 2

AltaMed’s English and Spanish telenovela webseries Sin Vergüenza (Without Shame) was developed to address the impact HIV has on the Latino community. Now in its second season, Sin Vergüenza highlights the importance of obtaining HIV medical treatment and support for coping with a diagnosis. While stigma and shame continue to be one of the greatest […]

Surviving the Streets: Challenges and Opportunities Addressing Youth Homelessness

Norweeta Milburn, PhD Department of Psychiatry & Biobehavioral Sciences David Geffen School of Medicine at UCLA About the Presenter Dr. Milburn is a Professor-in-Residence in the Department of Psychiatry and Biobehavioral Sciences at the UCLA Semel Institute Center for Community Health and Director of Research and Evaluation at the Nathanson Family Resilience Center. Her research […]

UCLA CFAR / AIDS Institute Grand Rounds: Robert M. Grant, MD, MPH – “PrEP Scale-up for Impact”

Robert M. Grant, MD, MPH Senior Investigator, Professor of Medicine Gladstone Institutes, University of California San Francisco “PrEP Scale-up for Impact” Hosted by the International Health Services and Policy Program Section

Tiffany Cvrkel, PhD at CHIPTS Methods Seminar – UCLA-Semel Institute Center for Community Health

The Ethics of PrEP: Vulnerable Populations, Limited Resources, and the Public Good   Tiffany Cvrkel, PhD Bioethicist Molecular, Cell, & Developmental Biology University of California, Los Angeles     With evidence mounting that some combinations of antiretroviral agents may be used effectively as “pre-exposure prophylaxis” (PrEP) to prevent the spread of HIV, clinicians, researchers, and […]

Awareness Campaign Helps Those Most At-Risk Stay HIV Negative

           “The Protectors” Encourages Residents to Get Protected with PrEP.   LOS ANGELES – LOS ANGELES – Today, the Los Angeles County Department of Public Health (Public Health) unveiled its first-ever comprehensive public education campaign to raise awareness about Pre-Exposure Prophylaxis (PrEP), a once daily medication (Truvada ®) to prevent the transmission of HIV among uninfected […]

CDC’s New Risk Reduction Tool: Exploring Prevention Options

May 2, 2016 • By David W. Purcell, JD, PhD, Deputy Director, Behavioral and Social Science, Division of HIV/AIDS Prevention, NCHHSTP, CDC David Purcell New biomedical approaches to HIV, such as routine use of ART to treat and prevent HIV, and the use of PrEP and PEP, require changes and greater precision in how we […]

UCLA AI/CFAR Grand Rounds: Dr. Pamela Collins -“Grand Challenges: Integrating Mental Health in Research, Policy, Practice”

Pamela Y. Collins, MD, MPH National Institute of Mental Health “Grand Challenges: Integrating Mental Health in Research, Policy, Practice” Grand Rounds is offered by the UCLA CFAR / AIDS Institute, consists of hour-long lunchtime lectures, delivered by invited guests or distinguished members of the Institute faculty, on a broad range of subjects. The aims of the […]

Dr. Shoptaw Speaks at UN Meeting

Dr. Steven Shoptaw, CHIPTS Co-Director, will be giving an invited address on March 11, 2016 in Vienna, Austria, at a meeting of the United Nations Office on Drugs and Crime. The purpose of the U.N. meeting is to develop science-based recommendations on ensuring access to antiretroviral therapies for people living with HIV/AIDS who also use […]